Correlation Between AptaBio Therapeutics and Daewoo SBI

Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Daewoo SBI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Daewoo SBI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AptaBio Therapeutics and Daewoo SBI SPAC, you can compare the effects of market volatilities on AptaBio Therapeutics and Daewoo SBI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Daewoo SBI. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Daewoo SBI.

Diversification Opportunities for AptaBio Therapeutics and Daewoo SBI

0.74

Correlation Coefficient

AptaBio Therapeutics  Daewoo SBI

Poor diversification

The 3 months correlation between AptaBio and Daewoo is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Daewoo SBI SPAC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daewoo SBI SPAC and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Daewoo SBI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daewoo SBI SPAC has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Daewoo SBI go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Daewoo SBI

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Daewoo SBI. In addition to that, AptaBio Therapeutics is 2.31 times more volatile than Daewoo SBI SPAC. It trades about -0.17 of its total potential returns per unit of risk. Daewoo SBI SPAC is currently generating about -0.19 per unit of volatility. If you would invest  291,000  in Daewoo SBI SPAC on August 30, 2024 and sell it today you would lose (51,000) from holding Daewoo SBI SPAC or give up 17.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

AptaBio Therapeutics  vs.  Daewoo SBI SPAC

AptaBio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Daewoo SBI SPAC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Daewoo SBI SPAC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with AptaBio Therapeutics and Daewoo SBI

The main advantage of trading using opposite AptaBio Therapeutics and Daewoo SBI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Daewoo SBI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daewoo SBI will offset losses from the drop in Daewoo SBI's long position.

The idea behind AptaBio Therapeutics and Daewoo SBI SPAC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.